Form 4: J. Robert Kerrey Receives Tenet Healthcare Equity Grant

Director J. Robert Kerrey was granted 1,464 restricted stock units by Tenet Healthcare Corporation.

Summary

• Director J. Robert Kerrey received a grant of 1,464 restricted stock units (RSUs) on May 27, 2026.
• Each RSU represents the economic equivalent of one share of Tenet Healthcare common stock.
• The units are scheduled to vest on May 27, 2027, one year after the grant date.
• The reporting person has the option to receive up to 37% of the vested units in cash rather than shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Standard market risks associated with equity ownership and potential volatility in Tenet Healthcare stock price.

Future Outlook

The restricted stock units are set to vest on May 27, 2027, at which point the director will receive shares or a combination of cash and shares.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practice to ensure directors maintain a vested interest in the company's long-term performance.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is consistent with standard compensation practices for large-cap healthcare companies.
• The one-year vesting schedule is a common retention and alignment mechanism used by peer healthcare organizations.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation grant.

Next Steps

• Vesting of the 1,464 restricted stock units on May 27, 2027.

Key Dates

Keywords

Tenet Healthcare, THC, Form 4, Insider Trading, Restricted Stock Units, Director Compensation